According to WHO, 6 .7 million people die from stroke every year. The search for new neuroprotective substances remains an urgent task. 
Design of the experiment. To study the neuroprotective effect of placental factors, a model of glutamate excitotoxicity (damage of neural cells (NCs) due to neurotransmitter overexcitation), which takes place in the pathogenesis of a number of neurological diseases (ischemia, traumatic injuries, neurodegenerative diseases) and is the standard method for studying neuroprotective activity [6, 9] was chosen. The study was divided into 3 stages ( Table 1) . At the first stage, the effect of media conditioned with placental explants, placenta derived MSCs and media According to WHO, stroke is the second leading cause of death after cardiovascular disease, and more than 6 million people die from it every year. The contribution of strokes to the mortality structure has increased over the last 10 years, as they are among the least curable diseases. In addition, in the developed countries, senile dementia and demyelinating diseases are the fourth leading cause of death [17] . The urgent task of modern medicine is the search for new effective treatments that reduce damage, prevent death and contribute to the restoration of neurons and glia [5, 7, 8] . Numerous studies have shown that therapy with mesenchymal stem cells (MSCs), including placental origin, can be effective in diseases of the nervous system, including strokes and traumas [3, 5, 19] . In addition, the positive effect of tissue, cellular factors [4, 16] , female sex hormones and placental extract on the nervous system was shown [2, 15, 18] . In this case, the mechanism of neuroprotective action of MSCs is associated with paracrine interactions, effects on neurons and glia [4, 8] . It can be assumed that the placenta derivatives, such as, stem cells as well as extract and explants (organotypic culture) will have neuroprotective and therapeutic effects. Placenta is one of the most accessible and promising sources
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with the addition of 10 % placental extract to NCs without glutamate was investigated. At the second stage, the neuroprotective (prophylactic) effect of the same media was investigated by NCs incubating with them for 1 day prior to glutamate treatment. At the third stage, the regenerating (curative) effect of substances on NCs after glutamate treatment was investigated. In all cases, both the effect of native media and media inactivated by heating to 90 °C for 30 minutes were investigated. The media conditioned with MSCs and placenta explants were used for 1 day according to the previously described protocol [10, 12] , the concentration of placental extract was previously empirically selected and was 10 % of the culture medium [1] . It was assumed that a day is enough for paracrine factors to enter the media, but is no time for media to deplete, or for saturating with the products of metabolism. Culture of neural cells. NCs were isolated from the brain of newborn Wistar rats on the first day after their birth by a previously developed method [14] . For this purpose, the tissue was disaggregated for 15 minutes in 0.25 % trypsin solution (BioWest, France) on phosphate buffered saline (PBS) at 37 °C. The cells were cultured in 6-well plates (SPL, Korea) in DMEM with high content of glucose and L-glutamine (BioWest, France) supplemented with 10 % fetal bovine serum (FBS) (Lonza, Germany) in a CO 2. incubator at 37 0 С in an atmosphere of 5 % CO 2. In 5 days after adhesion, the non-adherent cells were removed by washing with PBS. The remaining cells were removed with a solution of 0.25 % trypsin and Versene (EDTA) in a ratio of 1:1 and used in the glutamate excitotoxicity model. For this experiment, a culture containing various brain cells was chosen, since the mechanism of damage and regeneration is considered by several authors as processes of interaction of neurons with glia [4, 8] .
Model of glutamate excitotoxicity. For modeling glutamate excitotoxicity, he NCs were transferred to a 96 well plate at a concentration of 2•10 4 cells/well for 1 day for attachment, then the medium was replaced with the fresh one, with glutamate (Sigma, USA) in a final concentration of 10 mM and incubated for 1 day in the same conditions. To assess the metabolic activity of cells, MTT test was used. The wells were washed twice with PBS, the medium was changed to fresh. MTT (Sigma, USA) was added at a final concentration of 0.5 mg/ml, incubated for 4 hours, after which the medium was carefully selected, and the formazan crystals were dissolved with 10 % SDS solution on dimethyl sulfoxide (Sigma, France). The absorption was measured on plate spectrophotometer Utrao SM600 (China) at a wavelength of 570 nm. Each experiment was repeated on three different cell cultures, eight samples were taken from each. At the same time, the MTT test results for cells without glutamate treatment was taken as 100 %.
Obtaining of placental cryoextract. Placental extract was obtained by the previously described method [13] . The human placenta, delivered within 3 hours after cesarean section surgery, was fragmented, 2 parts of PBS were added to one part of the placental tissue, three times cooled by immersion in liquid nitrogen and heated in a water bath at 37 °C, centrifuged at 1500 rpm, the supernatant was taken.
The obtaining of medium conditioned with cryopreserved placental explants. The placental explant-conditioned medium was prepared by the previously described method [12] . 10 mg of cryopreserved placental explants were cultured in 24-well plates (SPL, Korea) for 1 day in 1 ml of DMEM with high content of glucose and L-glutamine (BioWest, France) supplemented with 10 % FBS (Lonza, Germany) in a CO 2 incubator at 37 °C in 5 % CO 2.
Obtaining of a medium conditioned with cryopreserved placenta derived mesenchymal cells. Placenta MSCs were obtained from fetal membranes by enzymatic method using 0.25 % trypsin [10] . The cells were previously phenotyped, there are CD90, CD73, CD105-positive, CD34-negative, and they are able to differentiate in osteogenic, adipogenic and chondrogenic lines [10, 11] . To obtain medium conditioned with cryopreserved MSCs, cells were thawed in a water bath at 37 °C. After reaching a monolayer about 1•10 6 per 5 ml medium in 25 cm 2 flask (SPL, Korea), the medium was changed, and cells were cultured for 1 day in DMEM with high content glucose and L-glutamine (BioWest, France) supplemented with 10 % FBS (Lonza, Germany) in a CO2 incubator at 37 °C in an atmosphere of 5 % CO2 .
Cryopreservation of placental cells and explants.
Placental explants and MSCs of the 3-4 passages were cryopreserved according to the previously used program [10, 12] , the effectiveness of which was shown [10, 11, 12] . As a cryoprotective medium we used DMEM with a high content of glucose and L-glutamine (BioWest, France) supplemented with 10 % FBS (Lonza, Germany) and 10 % dimethyl sulfoxide (Sigma, USA). Placental explants and MSCs were frozen in cryotubes (Nunc, USA) using containers Mr. Frosty™ Freezing Container (Thermo Fisher Scientific, USA) with isopropanol at a rate of 1 °C to -70 °C, followed by immersion in liquid nitrogen. They were thawed in a water bath at 37 °C.
Statistical analysis of results.
The results were statistically processed using the Mann-Whitney test with Past V. 3.15 (University of Oslo, Norway) software, the differences at p < 0.05 were significant.
At the first stage, the influence of media with placental factors on the metabolic activity of NCs was studied. After the addition of the medium conditioned with MSCs, the MTT value increased by more than 20 %. The medium with 10 % placental extract increased MTT by 30%, and the medium, conditioned with placental explants, increased it by more than 25 %. At the same time, as all these factors after inactivation by heating didn`t change NCs` metabolic activity (Fig. 1.) . This result agrees with the literature data on the study of neuroprotective properties of tissue factors [16] , where the hypothesis of the protein-peptide nature of substances affecting cells is given.
At the second stage, the neuroprotective effect of media containing placental factors was investigated by incubating NCs with them before glutamate treatment. It was found that the preliminary exposure of the medium with placental MSCs or 10 % placental extract makes NCs insensitive to glutamate, while the same medium, conditioned with organotypic placental culture, significantly reduces the sensitivity of NCs to glutamate. The same media, inactivated by heating, have no protective properties (Fig. 2) . At the third stage of the study, the regenerative effect of placental factors on NCs culture was studied. It is shown that after glutamate treatment and subsequent regeneration in media containing placental factors, the metabolic activity of the cells is restored, but not more than 50 % of the control value ( fig. 3) . In this case,, the media, inactivated by heating, show no effect on NCs. There were no significant differences between media, containing placental extract and media conditioned with placenta derived MSCs or placental explants.
Thus, at all three stages of the experiment, it has been shown that placental factors increase NCs` metabolic activity according to MTT test, regardless of their source: as media conditioned by the cell culture or by the organotypic culture of the placenta and placenta extract. This confirms the opinion about the paracrine effect of MSCs on NCs. The results of the study are consistent with the literature data on the neuroprotective effect of MSCs [3, 5, 7, 8] , placental [3, 15, 19] and tissue factors [16] . It is shown that the neuroprotective effect is achieved by humoral action directly on NCs, and not on the whole organism [5, 7, 8, 15, 19] . Thermolability leads to the assumption that the effect is achieved due to substances of protein-peptide nature, and not estrogens, as shown by a number of researchers [2, 18] . According to the experiments, we can not say about the advantages of these or other agents, since this requires the selection of concentrations that can differ for cell cultures, animal experiments, and clinical studies. At the same time, preventive use of placenta derivatives is more effective than their use after toxic effects, which can be regarded as neuroprotective action. It is advisable to consider derivatives of the placenta, primarily as a preventive and neuroprotective agent for NCs. In our opinion, it is promising to identify neuroprotective effects on different types of neural cells with subsequent detection of active substances and mechanisms of their effect at the next stages of the study. Notes: * -p <0.05 compared to the control. ** -p <0.05 compared to 10 Glu. 
